Rho Capital Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4 |
|
|
2022
Q2 | – | Sell |
-31,858
| Closed | -$3.18M | – | 4 |
|
|
2022
Q1 | $3.18M | Hold |
31,858
| – | – | 2.2% | 3 |
|
|
2021
Q4 | $4.95M | Hold |
31,858
| – | – | 3.22% | 3 |
|
|
2021
Q3 | $7.51M | Hold |
31,858
| – | – | 4.19% | 4 |
|
|
2021
Q2 | $10.8M | Hold |
31,858
| – | – | 0.99% | 6 |
|
|
2021
Q1 | $12.9M | Hold |
31,858
| – | – | 1.24% | 6 |
|
|
2020
Q4 | $21.2M | Hold |
31,858
| – | – | 11.15% | 3 |
|
|
2020
Q3 | $14.8M | Hold |
31,858
| – | – | 12.35% | 3 |
|
|
2020
Q2 | $18.6M | Hold |
31,858
| – | – | 12.07% | 3 |
|
|
2020
Q1 | $4.64M | Hold |
31,858
| – | – | 4.68% | 4 |
|
|
2019
Q4 | $4.56M | Hold |
31,858
| – | – | 3.47% | 4 |
|
|
2019
Q3 | $1.26M | Hold |
31,858
| – | – | 1.05% | 4 |
|
|
2019
Q2 | $3.23M | Hold |
31,858
| – | – | 2.24% | 4 |
|
|
2019
Q1 | $4.19M | Hold |
31,858
| – | – | 4.43% | 3 |
|
|
2018
Q4 | $3.25M | Hold |
31,858
| – | – | 4.77% | 3 |
|
|
2018
Q3 | $7.97M | Hold |
31,858
| – | – | 7.33% | 3 |
|
|
2018
Q2 | $14.2M | Hold |
31,858
| – | – | 13.61% | 3 |
|
|
2018
Q1 | $12.6M | Sell |
31,858
-863
| -3% | -$340K | 17.71% | 3 |
|
|
2017
Q4 | $13.4M | Hold |
32,721
| – | – | 23.36% | 2 |
|
|
2017
Q3 | $14.1M | Hold |
32,721
| – | – | 22.27% | 2 |
|
|
2017
Q2 | $11.4M | Buy |
+32,721
| New | +$11.4M | 15.96% | 2 |
|